Immatics (IMTX) EBIT Margin (QoQ) (2019 - 2025)
Immatics (IMTX) EBIT Margin (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Immatics | 1.11 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 80,138.00 |
| Sep 30, 2025 | 100,454.00 |
| Jun 30, 2025 | -169,542.00 |
| Mar 31, 2025 | -37,126.00 |
| Dec 31, 2024 | 10,921.00 |
| Sep 30, 2024 | 6,726.00 |
| Jun 30, 2024 | -8,889.00 |
| Mar 31, 2024 | 17,449.00 |
| Dec 31, 2023 | 29,116.00 |
| Sep 30, 2023 | -35,836.00 |
| Jun 30, 2023 | 12,219.00 |
| Mar 31, 2023 | -21,389.00 |
| Dec 31, 2022 | 11,462.00 |
| Sep 30, 2022 | -6,121.00 |
| Jun 30, 2022 | -15,908.00 |
| Mar 31, 2022 | 19,097.00 |
| Dec 31, 2021 | 31,605.00 |
| Sep 30, 2021 | 9,861.00 |
| Jun 30, 2021 | -19,878.00 |
| Mar 31, 2021 | -6,869.00 |